CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is ...
View CERo Therapeutics Holdings stock forecast data, including CERO stock price estimates and 12-month CERo Therapeutics Holdings price targets, to assess potential upside or downside. Compare CERO ...
Upgrade to begin using 40 years of financial statements and get so much more. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results